Testing for latent tuberculosis infection using interferon gamma release assays in commercial sex workers at an outreach clinic in Birmingham

Abstract

This report demonstrates that using interferon gamma release assays to screen for latent tuberculosis infection in female commercial sex workers in an outreach sexual health clinic is feasible and acceptable. Routine interferon gamma release assay use successfully identified high numbers of latent tuberculosis infection. Innovative approaches to treatment and follow up were required to improve treatment adherence in this group. Direct observation of therapy within the sexual health clinic was also feasible. Successful follow up was dependent on the support of outreach workers, interpreters and tuberculosis nurses.

Keywords

Screening sex workers women tuberculosis interferon gamma release assay IGRA latent infection

Get full access to this article

View all access options for this article.

References

Public Health England. Collaborative Tuberculosis Strategy for England 2015–2020, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/403231/Collaborative_TB_Strategy_for_England_2015_2020_.pdf (2015, accessed 29 July 2015).

Public Health England. TB rates in the West Midlands higher than national average, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/231028/TB_2013_annual_report_West_Midlands_press_release.pdf (2013, accessed 29 July 2015).

Public Health England. Tuberculosis in the UK: 2014 report, London: Public Health England, 2014.

World Health Organisation. Guidelines on the management of Latent Tuberculosis Infection. 2015 WHO/HTM/TB/2015.01.

Public Health England. Tuberculosis rates by country in 2013 (worldwide table), https://www.gov.uk/government/publications/tuberculosis-tb-by-country-rates-per-100000-people (2014, accessed 29 July 2015).

University College London Institute of Health Equity. A review of the literature on sex workers and social exclusion. Report. University College London, April 2014.

Lönnroth

Williams

Stadlin

. Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health 2008; 8: 289–289.

Story

Murad

Verheyen

. Tuberculosis in London – the importance of homelessness, problem drug use and prison. Thorax 2007; 62: 667–671.

Ferrara

. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328–1334.

10.

Zwerling

. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med 2011; 8: e1001012–e1001012.

11.

Sterling

Villarino

Borisov

. Three months of rifapentine and isoniazid for latent tuberculosis infection. New Engl J Med 2011; 365: 2155–2166.

12.

Jereb

Goldberg

Powell

. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR 2011; 60: 1650–1653.

13.

Bates

Khalakdina

Pai

. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 335–342.

14.

Slama

Chiang

Enarson

. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007; 11: 1049–1061.

15.

World Health Organisation. The Stop TB Strategy, http://whqlibdoc.who.int/hq/2006/WHO_HTM_STB_2006.368_eng.pdf?ua=1 (2006, accessed 29 July 2015).